ISSN 2073–4034
eISSN 2414–9128

The Drug Hepabene In The Therapy Of Hepatobiliary System Diseases

S.A. Bulgakov

The drug Hepabene in the therapy of hepatobiliary system diseases
We presented data for many studies on the therapeutic efficacy of Hepabene having hepatoprotective, choleretic and spasmolytic properties, in patients with hepatobiliary system diseases. Positive properties of the drug are determined by the qualities of its component plants - Silybum marianum fruit extract and Fumaria officinalis herbs extract. The clinical trials data analyses confirmed the Hepabene effectiveness in the treatment of hepatobiliary system diseases and allowed us to formulate a list of indications for this drug administration. They are all kinds of biliary dyskinesia, chronic liver disease, including steatosis and toxic injury. We highlight the importance of Gepabene administration in patients with liver steatosis caused by metabolic syndrome and type 2 diabetes mellitus.

Keywords

hepatoprotectors
flavonoids
silibinin
fumarin
Gepabene
hepatobiliary system

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.